Eplerenone in patients with systolic heart failure and mild symptoms

Zannad, Faiez, McMurray, John J.V., Krum, Henry, van Veldhuisen, Dirk J., Swedberg, Karl, Shi, Harry, Vincent, John, Pocock, Stuart J. +1 more·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1009492

Cited by (1,005)

Items 201–300 of 1,005

Hyponatremia in Acute Decompensated Heart Failure
Frederik Hendrik Verbrugge, Paul Steels, Lars Grieten, Petra Nijst, W.H. Wilson Tang, Wilfried Müllens · 2015 · Journal of the American College of Cardiology
Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
Peter Kolkhof, Steffen A. Borden · 2011 · Molecular and Cellular Endocrinology
Role of Rac1–mineralocorticoid-receptor signalling in renal and cardiac disease
Miki Nagase, Toshiro Fujita · 2013 · Nature Reviews Nephrology
The 2011 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Sleep Apnea, Renal Dysfunction, Mechanical Circulatory Support, and Palliative Care
Robert Samuel McKelvie, Gordon Willy Pak Ling Moe, Anson W. Cheung, Jeannine Costigan, Anique Ducharme, Estrellita Estrella-Holder, Justin Adrian Ezekowitz, John S. Floras, Nadia Giannetti, Adam Grzeslo et al. · 2011 · Canadian Journal of Cardiology
Novel RAAS agonists and antagonists: clinical applications and controversies
César A. Romero, Marcelo Orías, Matthew R. Weir · 2015 · Nature Reviews Endocrinology
2011 Update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006
Henry Krum, Michael V Jelinek, Simon Stewart, Andrew Paul Sindone, John James Atherton · 2011 · The Medical Journal of Australia
Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction
Jordan B. King, Rashmee U. Shah, Adam Phillip Bress, Richard E. Nelson, Brandon Kyle Bellows · 2016 · JACC Heart Failure
Renal Effects of Guideline-Directed Medical Therapies in Heart Failure: A Consensus Document from the Heart Failure Association of the European Society of Cardiology
Wilfried Müllens, Pieter Martens, Jeffrey Moore Testani, W.H. Wilson Tang, Hadi N. Skouri, Frederik Hendrik Verbrugge, Marat Fudim, Massimo Iacoviello, Jennifer Franke, Andreas J. Flammer et al. · 2022 · European Journal of Heart Failure
Pathological Ventricular Remodeling
Min Xie, Jana S. Burchfield, Joseph A. Hill · 2013 · Circulation
Outcomes and Effect of Treatment According to Etiology in HFrEF
Craig Balmforth, Joanne Simpson, Li Shen, Pardeep S. Jhund, Martin P. Lefkowitz, Adel R. Rizkala, Jean Lucien Rouleau, Victor Chengwei Shi, Scott David Solomon, Karl B Swedberg et al. · 2019 · JACC Heart Failure
Heart Failure in Older Adults
Hoda Butrous, Scott L. Hummel · 2016 · Canadian Journal of Cardiology
Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan, Kosiborod, Mikhail N., Lekavich, Carolyn L. et al. · 2019 · Journal of Cardiac Failure
Therapeutic Targets in Heart Failure
Erik B. Schelbert, Gregg C. Fonarow, Robert O. Bonow, Javed Butler, Mihai Gheorghiade · 2014 · Journal of the American College of Cardiology
Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
Jagadish Khanagavi, Tanush Gupta, Wilbert S. Aronow, Tushar M. Shah, Jalaj Garg, Chul Woo Ahn, Sachin S. Sule, Stephen Peterson · 2014 · Archives of Medical Science
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Jean‐Philippe Bertocchio, David G. Warnock, Frédéric Jaisser · 2011 · Kidney International
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
Adrian F. Hernandez, Xiaojuan Mi, Bradley G. Hammill, Stephen C. Hammill, Paul A. Heidenreich, Frederick A. Masoudi, Laura Goettinger Qualls, Eric David Peterson, Gregg C. Fonarow, Lesley H. Curtis · 2012 · JAMA
Perceptions and Experiences of Heart Failure Patients and Clinicians on the Use of Mobile Phone-Based Telemonitoring
Emily Seto, Kevin J. Leonard, Joseph Antony Cafazzo, Jan M. Barnsley, Caterina Masino, Heather Joan Ross · 2012 · Journal of Medical Internet Research
Is Europe putting theory into practice? A qualitative study of the level of self-management support in chronic care management approaches
Arianne Elissen, Ellen Nolte, Cécile Knai, Matthias Brunn, Karine Chevreul, Annalijn Conklin, Isabelle Durand‐Zaleski, Antje Erler, Maria Flamm, Anne Frølich et al. · 2013 · BMC Health Services Research
Management of Low Blood Pressure in Ambulatory Heart Failure with Reduced Ejection Fraction Patients
Jennifer Cautela, Jean‐Michel Tartière, Alain Cohen Solal, Anne Bellemain-Appaix, Alexis Théron, Thierry Tibi, James L. Januzzi, François Roubille, Nicolas Girerd · 2020 · European Journal of Heart Failure
The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure
McKelvie, Robert S., Moe, Gordon W., Ezekowitz, Justin A., Heckman, George A., Costigan, Jeannine, Ducharme, Anique, Estrella-Holder, Estrellita, Giannetti, Nadia, Grzeslo, Adam, Harkness, Karen et al. · 2013 · Canadian Journal of Cardiology
Early Treatment With Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy Mice
Jill A. Rafael‐Fortney, Neeraj S. Chimanji, Kevin E. Schill, Christopher D. Martin, Jason D. Murray, Ranjit Ganguly, Jenna E. Stangland, Tam Tran, Ying Xu, Benjamin D. Canan et al. · 2011 · Circulation
Early Aldosterone Blockade in Acute Myocardial Infarction
Farzin Beygui, Guillaume Cayla, Vincent Roule, François Roubille, Nicolas Delarche, Johanne Silvain, Eric VAN BELLE, Loïc Belle, Michel Galinier, Pascal Motreff et al. · 2016 · Journal of the American College of Cardiology
Cardiovascular disease in chronic kidney disease
Katharina Marx-Schütt, David Z.I. Cherney, Joachim Jankowski, Kunihiro Matsushita, Massimo Nardone, Nikolaus Marx · 2025 · European Heart Journal
Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
Kiyoshi Arai, Tsuyoshi Homma, Yuka Morikawa, Naoko Ubukata, Hiyoyuki Tsuruoka, Kazumasa Aoki, Hirokazu Ishikawa, Makoto Mizuno, Toshio Sada · 2015 · European Journal of Pharmacology
Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death
Paul A. Bottomley, Gurusher Singh Panjrath, Shenghan Lai, Glenn A. Hirsch, Kathérine C. Wu, Samer S. Najjar, Angela M. Steinberg, Gary Gerstenblith, Robert George Weiss · 2013 · Science Translational Medicine
Rationale and Design of The SOluble guanylate Cyclase StimulatoR in HeArT FailurE Studies (SOCRATES)
Burkert Mathias Pieske, Javed Butler, Gerasimos S Filippatos, Carolyn S.P. Lam, Aldo Pietro Maggioni, Piotr P. Ponikowski, Sanjiv Jayendra Shah, Scott David Solomon, Elisabeth Kraigher‐Krainer, Eliana Sueco Tibana Samano et al. · 2014 · European Journal of Heart Failure
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
Marco Roffi, Carlo Patrono, Jean‐Philippe Collet, Christian Eugen Mueller, Marco Valgimigli, Felicita Andreotti, Jeroen Joost Bax, Michael Andrew Borger, Carlos Brotons, Derek P. Chew et al. · 2015 · Revista Española de Cardiología (English Edition)
The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation
Daniel Lavall, Christian Selzer, Pia Schuster, Matthias Lenski, Oliver Adam, Hans‐Joachim Schäfers, Michael Böhm, Ulrich Laufs · 2014 · Journal of Biological Chemistry
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos S Filippatos, João Pedro Ferreira, Stuart Pocock, Hans‐Peter Brunner‐La Rocca, Stefan P. Janssens, Hiroyuki Tsutsui, Jian Zhang et al. · 2020 · European Heart Journal
2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
О. Л. Барбараш, Dmitry Viktorovich Duplyakov, D. A. Zateischikov, Е. П. Панченко, Roman M. Shakhnovich, I. S. Yavelov, Aleksey N. Yakovlev, Abugov Sa, Bagrat G. Alekyan, Архипов Михаил Викторович et al. · 2021 · Russian Journal of Cardiology
The STICH Trial (Surgical Treatment for Ischemic Heart Failure)
Peter E. Carson, JOHN H. WERTHEIMER, Alan Bruce Miller, Christopher M. O’Connor, Ileana L. Piña, Craig H. Selzman, Carla A. Sueta, Lilin She, Deborah Greene, Kerry L. Lee et al. · 2013 · JACC Heart Failure
Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors
Dafina Pruthi, Amy McCurley, Mark A. Aronovitz, Carol Galayda, S. Ananth Karumanchi, Iris Zamir Jaffe · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
Mineralocorticoid Receptor and Cardiovascular Disease
Mathieu Buonafine, Benjamin Bonnard, Frédéric Jaisser · 2018 · American Journal of Hypertension
Atualização da diretriz brasileira de insuficiência cardíaca crônica - 2012
EA Bocchi, Fabiana G. Marcondes‐Braga, Fernando Bacal, AS Ferraz, D Albuquerque, D Rodrigues · 2012 · Arquivos Brasileiros de Cardiologia
Novel therapeutic targets for the treatment of heart failure
Juan Luis Tamargo, Jose Luis Lopez-Sendon · 2011 · Nature Reviews Drug Discovery
Heart Failure Oral Therapies at Discharge are Associated with Better Outcome in Acute Heart Failure: A Propensity-Score Matched Study
Étienne Gayat, Mattia Arrigo, Simona Littnerová, Naoki Sato, Jiří Pařenica, Shiro Ishihara, Jindřich Špinar, Christian Eugen Mueller, Veli‐Pekka Harjola, Johan P.E. Lassus et al. · 2014 · European Journal of Heart Failure
Aldosterone, mineralocorticoid receptor, and heart failure
Smail Messaoudi, Fériel Azibani, Claude Delcayre, Frédéric Jaisser · 2011 · Molecular and Cellular Endocrinology
Treatment of Hypertension in Patients With Coronary Artery Disease
Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger Scott Blumenthal, Christopher Paul Cannon, James A. de Lemos, W.J. Elliott, Laura Findeiss et al. · 2015 · Journal of the American College of Cardiology
Dilated Cardiomyopathy
Neal K. Lakdawala, Jeffery R. Winterfield, Birgit Funke · 2012 · Circulation Arrhythmia and Electrophysiology
Pathophysiology of Cardiorenal Syndrome Type 2 in Stable Chronic Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
Dinna N. Cruz, Kai Martin Schmidt-Ott, Giorgio Vescovo, Andrew A. House, John A. Kellum, Claudio Ronco, Peter Andrew McCullough, for the Acute Dialysis Quality Initiative (ADQI) Consensus Group · 2013 · Contributions to nephrology
Chronic Heart Failure
Ryan P. Morrissey, Lawrence S.C. Czer, Prediman K. Shah · 2011 · American Journal of Cardiovascular Drugs
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease
Andreas Tomaschitz, Eberhard Ritz, Burkert Mathias Pieske, Astrid Fahrleitner‐Pammer, Katharina Kienreich, Jörg H. Horina, Christiane Drechsler, Winfried März, Michael Ofner, Thomas Rudolf Pieber et al. · 2012 · Cardiovascular Research
A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome
Wojciech Kosmala, Monika Przewłocka‐Kosmala, Hanna Szczepanik-Osadnik, Andrzej Mysiak, Trisha M O'Moore‐Sullivan, Thomas Hugh Marwick · 2011 · JACC. Cardiovascular imaging
Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
Hirotaka Shibata, H. Itoh · 2012 · American Journal of Hypertension
Renin–Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation
Thomas G. von Lueder, S. Jeson Sangaralingham, Bing Hui Wang, Andrew R. Kompa, Dan Atar, John C. Jr Burnett, Henry Krum · 2013 · Circulation Heart Failure
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
Nicole Martin, Karthick Manoharan, James Thomas, Ceri Davies, R Thomas Lumbers · 2018 · Cochrane Database of Systematic Reviews
Comparing LCZ696 With Enalapril According to Baseline Risk Using the MAGGIC and EMPHASIS-HF Risk Scores
Joanne Simpson, Pardeep S. Jhund, José Silva‐Cardoso, Felipe Martinez, Arend Mosterd, Félix José Alvarez Ramires, Adel R. Rizkala, Michele Senni, Iain B Squire, Jianjian Gong et al. · 2015 · Journal of the American College of Cardiology
Heart Failure in Women
Biykem Bozkurt, Shaden Z. Khalaf · 2017 · Methodist DeBakey Cardiovascular Journal
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Dragomir Chioncel et al. · 2022 · Revista Española de Cardiología
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
Rienstra, Michiel, Tzeis, Stylianos, Bunting, Karina V, Caso, Valeria, Crijns, Harry J G M, De Potter, Tom J R, Sanders, Prashanthan, Svennberg, Emma, Casado-Arroyo, Ruben, Dwight, Jeremy et al. · 2024 · Europace
Cardioprotective function of cardiac macrophages
Katsuhito Fujiu, Jingjing Wang, R Nagai · 2014 · Cardiovascular Research
Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance
Otávio R. Coelho‐Filho, Ravi V. Shah, Richard N. Mitchell, Tomas G. Neilan, Heitor Moreno, Bridget Simonson, Raymond K. Kwong, Anthony Rosenzweig, Saumya Das, Michael Jerosch‐Herold · 2013 · Circulation
Key inflammatory mechanisms underlying heart failure
Christian Riehle, Johann K Bauersachs · 2019 · Herz
Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021
Fabiana G. Marcondes‐Braga, Lídia Zytynski Moura, Victor Sarli Issa, Jefferson Luís Vieira, Luís Eduardo Paim Rohde, Marcus Vinı́cius Simões, Miguel Morita Fernandes-Silva, Salvador Rassi, Sílvia Marinho Martins, Denílson Campos de Albuquerque et al. · 2021 · Arquivos Brasileiros de Cardiologia
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Silvia Giuliana Priori, Carina Blomström‐Lundqvist, Andrea Mazzanti, Nico A. Blom, Martin Borggrefe, A. John Camm, Perry M Elliot, Donna Fitzsimons, Róbert Hatala, Gerhard Hindricks et al. · 2016 · Revista Española de Cardiología (English Edition)
Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency
Damman, Kevin, Tang, W.H. Wilson, Felker, G. Michael, Lassus, Johan, Zannad, Faiez, Krum, Henry, McMurray, John J.V. · 2014 · Journal of the American College of Cardiology
Eficacia de un programa integrado hospital-atención primaria para la insuficiencia cardiaca: análisis poblacional sobre 56.742 pacientes
Josep Comin Colet, José María Verdú-Rotellar, Emili Vela, Montse Clèries, Montserrat Bustins, Lola Mendoza, Neus Badosa, Mercedes Cladellas, Sofía Ferré, Jordi Bruguera · 2014 · Revista Española de Cardiología
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA ( Vericiguat Global Study in Subjects with HFrEF ) trial
Adriaan A. Voors, Hillary S. Mulder, Eugene B. Reyes, Martín Cowie, Johan P.E. Lassus, Adrian F. Hernandez, Justin Adrian Ezekowitz, Javed Butler, Christopher M. O’Connor, Joerg Koglin et al. · 2021 · European Journal of Heart Failure
Therapeutic Advances in Diabetic Nephropathy
Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani, Ali Mehdi · 2022 · Journal of Clinical Medicine
Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy
Naoki Okumura, Pardeep S. Jhund, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Jean Lucien Rouleau, Victor Chengwei Shi, Karl B Swedberg, Michael R. Zile, Scott David Solomon et al. · 2016 · Circulation Heart Failure
Chronic Kidney Disease as a Comorbidity in Heart Failure
Magdalena Szlagor, Jill Dybiec, Ewelina Młynarska, Jacek Rysz, Beata Franczyk · 2023 · International Journal of Molecular Sciences
Evaluation of Continuous Positive Airway Pressure Therapy on Renin–Angiotensin System Activity in Obstructive Sleep Apnea
Nicholl, David D. M., Hanly, Patrick J., Poulin, Marc J., Handley, George B., Hemmelgarn, Brenda R., Sola, Darlene Y., Ahmed, Sofia B. · 2014 · American Journal of Respiratory and Critical Care Medicine
The past, present and future of renin–angiotensin aldosterone system inhibition
Robert John Mentz, George L. Bakris, Bernard Waeber, John J.V. McMurray, Mihai Gheorghiade, Luis Miguel Ruilope, Aldo Pietro Maggioni, Karl B Swedberg, Ileana L. Piña, Mona Fiuzat et al. · 2012 · International Journal of Cardiology
A reappraisal of loop diuretic choice in heart failure patients
Jonathan Buggey, Robert John Mentz, Bertram Pitt, Eric L. Eisenstein, Kevin Joseph Anstrom, Eric J. Velazquez, Christopher M. O’Connor · 2015 · American Heart Journal
Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness
Guillaume Galmiche, Anne Pizard, Alexandre Gueret, Soumaya El Moghrabi, Antoine Ouvrard‐Pascaud, Stefan Berger, Pascal Challande, Iris Zamir Jaffe, Carlos Labat, Patrick J. Lacolley et al. · 2013 · Hypertension
Effect of Oral Digoxin in High-Risk Heart Failure Patients: A Pre-Specified Subgroup Analysis of the DIG Trial
Mihai Gheorghiade, Kanan Patel, Gerasimos S Filippatos, Stefan D. Anker, Dirk Jan van Veldhuisen, John G.F. Cleland, Marco Metra, Inmaculada Aban, Stephen John Greene, Kirkwood F. Adams et al. · 2013 · European Journal of Heart Failure
Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction
Wojciech Kosmala, Aleksandra Rojek, Monika Przewłocka‐Kosmala, Leah M. Wright, Andrzej Mysiak, Thomas Hugh Marwick · 2016 · Journal of the American College of Cardiology
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
Agarwal, Rajiv, Anker, Stefan D, Bakris, George, Filippatos, Gerasimos, Pitt, Bertram, Rossing, Peter, Ruilope, Luis, Gebel, Martin, Kolkhof, Peter, Nowack, Christina et al. · 2022 · Nephrology Dialysis Transplantation
Improving exercise capacity and quality of life using non‐invasive heart failure treatments: evidence from clinical trials
Stephan von Haehling, Michael E. Arzt, Wolfram Doehner, Frank Edelmann, Ruben Evertz, Nicole Ebner, Christoph Herrmann‐Lingen, Tania Garfias‐Veitl, Michael Johann Koziolek, Michel Noutsias et al. · 2020 · European Journal of Heart Failure
Causes and treatment of oedema in patients with heart failure
Clark, Andrew L., Cleland, John G. F. · 2013 · Nature Reviews Cardiology
The Ubiquitous Mineralocorticoid Receptor: Clinical Implications
Urseline A. Hawkins, Elise P. Gómez-Sánchez, Clara M. Gomez-Sanchez, Celso E. Gómez-Sánchez · 2012 · Current Hypertension Reports
Effect of Eplerenone in Patients with Heart Failure and Reduced Ejection Fraction: Potential Effect Modification by Abdominal Obesity. Insight from the Emphasis-Hf Trial
Arnaud Olivier, Bertram Pitt, Nicolas Girerd, Zohra Lamiral, Jean‐Loup Machu, John J.V. McMurray, Karl B Swedberg, Dirk Jan van Veldhuisen, Timothy John Collier, Stuart Pocock et al. · 2017 · European Journal of Heart Failure
Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
Gianluigi Savarese, Hong Xu, Marco Trevisan, Ulf Dahlström, Patrick Rossignol, Bertram Pitt, Lars H. Lund, Juan Jesús Carrero · 2018 · JACC Heart Failure
Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis
Neefs, J., van den Berg, N.W.E., Limpens, J., Berger, W.R., Boekholdt, S.M., Sanders, P., de Groot, J.R. · 2017 · International Journal of Cardiology
I Diretriz Brasileira de Cardio-Oncologia da Sociedade Brasileira de Cardiologia
Roberto Kalil Filho, LA Hajjar, Fernando Bacal, Paulo Marcelo Hoff, Maria Del Pilar Estevez-Diz, FRBG Galas · 2011 · Arquivos Brasileiros de Cardiologia
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
Greg H. Tesch, Morag J. Young · 2017 · Frontiers in Pharmacology
Management of Heart Failure Patient with CKD
Debasish Banerjee, Giuseppe Rosano, Charles A. Herzog · 2021 · Clinical Journal of the American Society of Nephrology
Potential of resveratrol in the treatment of heart failure
Pema Raj, Xavier Lieben Louis, Sijo Joseph Thandapilly, Ali Movahed, Shelley R. Zieroth, Thomas Netticadan · 2013 · Life Sciences
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension
GianLuca Colussi, Cristiana Catena, Leonardo Antonio Sechi · 2012 · Journal of Hypertension
The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature
Zachary Belden, Jeffrey A. Deiuliis, Mirela A. Dobre, Sanjay Rajagopalan · 2017 · American Journal of Nephrology
The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure
Nicola Riccardo Pugliese, Stefano Masi, Stefano Taddei · 2019 · Heart Failure Reviews
Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause
Luís Eduardo Paim Rohde, Neal A. Chatterjee, Muthiah Vaduganathan, Brian Lee Claggett, Milton Packer, Akshay Suvas Desai, Michael R. Zile, Jean Lucien Rouleau, Karl B Swedberg, Martin P. Lefkowitz et al. · 2020 · JACC Heart Failure
The Cardiorenal Syndrome in Heart Failure
Kevin Damman, Adriaan A. Voors, Gerjan J Navis, Dirk Jan van Veldhuisen, Hans L. Hillege · 2011 · Progress in Cardiovascular Diseases
Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction
Antonio Lax, Jesús Sánchez‐Más, M. Lopez, Maria Josefa Fernández‐Del Palacio, Luis Caballero, Iris Paula Garrido, Francisco J. Pastor‐Pérez, James L. Januzzi, Domingo Andrés Pascual-Figal · 2014 · JACC Heart Failure
The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice
Jonathan G. Howlett, Michael C. Y. Chan, Justin Adrian Ezekowitz, Karen I. Harkness, George A. Heckman, Simon Kouz, Marie-Hélène Leblanc, Gordon Willy Pak Ling Moe, Eileen O’Meara, Howard B. Abrams et al. · 2015 · Canadian Journal of Cardiology
A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model
Ramin Shadman, Jeanne E. Poole, Todd Dardas, Dariush Mozaffarian, John G.F. Cleland, Karl B Swedberg, Aldo Pietro Maggioni, Inder S. Anand, Peter E. Carson, Alan Bruce Miller et al. · 2015 · Heart Rhythm
Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade
Kosmala, Wojciech, Przewlocka-Kosmala, Monika, Szczepanik-Osadnik, Hanna, Mysiak, Andrzej, Marwick, Thomas H · 2013 · Heart
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
David M. Charytan, Jonathan Himmelfarb, Talat Alp Ikizler, Dominic S. Raj, Jesse Y. Hsu, John Richard Landis, Amanda Hyre Anderson, Adriana M. Hung, Rajnish Mehrotra, Shailendra Sharma et al. · 2018 · Kidney International
Oxidative Stress Causes Mineralocorticoid Receptor Activation in Rat Cardiomyocytes
Miki Nagase, Nobuhiro Ayuzawa, Wakako Kawarazaki, Kenichi Ishizawa, Kohei Ueda, Shigetaka Yoshida, Toshiro Fujita · 2012 · Hypertension
Care Gaps in Adherence to Heart Failure Guidelines
Jarjour, Marilyne, Henri, Christine, de Denus, Simon, Fortier, Annik, Bouabdallaoui, Nadia, Nigam, Anil, O’Meara, Eileen, Ahnadi, Charaf, White, Michel, Garceau, Patrick et al. · 2020 · JACC: Heart Failure
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor
Stefanie Ruhs, Alexander Nolze, Ralf Hübschmann, Claudia Großmann · 2017 · Journal of Endocrinology
Plasma Aldosterone Levels are Elevated in Patients with Pulmonary Arterial Hypertension in the Absence of Left Ventricular Heart Failure: A Pilot Study
Bradley A. Maron, Alexander R. Opotowsky, Michael Job Landzberg, Joseph Loscalzo, Aaron B. Waxman, Jane A. Leopold · 2012 · European Journal of Heart Failure
Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease
Nicholas C. Bene, Pilar Alcaide, Henry H. Wortis, Iris Zamir Jaffe · 2014 · Steroids
Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension
Karns, Adam D., Bral, Jacqueline M., Hartman, Daniel, Peppard, Thomas, Schumacher, Christoph · 2013 · The Journal of Clinical Hypertension
Aldosterone synthase inhibition in humans
Michel Azizi, Laurence Amar, Joël Ménard · 2012 · Nephrology Dialysis Transplantation
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
DAVID H. FITCHETT, Jacob Allen Udell, Silvio E. Inzucchi · 2016 · European Journal of Heart Failure
Neutrophil Gelatinase–Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids
Antoine Tarjus, Ernesto Martínez‐Martínez, Cristián A. Amador, Céline Latouche, Soumaya El Moghrabi, Thorsten Berger, Tak W. Mak, Renaud Fay, Nicolette Farman, Patrick Rossignol et al. · 2015 · Hypertension
Role of Mineralocorticoid Receptor Antagonists in Cardiovascular Disease
Carlos Maria Ferrario, Ernesto L. Schiffrin · 2014 · Circulation Research
Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis
John G.F. Cleland, Valentina Carubelli, Teresa Castiello, Ashraf Yassin, Pierpaolo Pellicori, Renjith Antony · 2012 · Heart Failure Reviews
Mineralocorticoid Receptor Antagonist Pattern of Use in Heart Failure with Reduced Ejection Fraction: Findings from BIOSTAT-CHF
João Pedro Ferreira, Patrick Rossignol, Jean‐Loup Machu, Abhinav Sharma, Nicolas Girerd, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Hans L. Hillege et al. · 2017 · European Journal of Heart Failure